🇺🇸
United States · US · US:63083-4449_bc143fb1-d232-4a0e-bc1f-6eab849fb0e4
H3N2 Influenza Nosode
UNIISPL
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerProfessional Complementary Health Formulas
CountryUS (United States)
ATC code—
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 1
- ndc11630834449259 mL in 1 BOTTLE, DROPPER (63083-4449-2)
Annotations
UNII (FDA Substance ID)
03723AG82F
INFLUENZA A VIRUS A/SOUTH AUSTRALIA/55/2014 IVR-175 (H3N2) NEURAMINIDASE ANTIGEN (PROPIOLACTONE INACTIVATED)
DailyMed SPL labels
1 version tracked
Raw payload (JSON)
{
"unii": {
"unii": "03723AG82F",
"rxcui": null,
"inchikey": null,
"display_name": "INFLUENZA A VIRUS A/SOUTH AUSTRALIA/55/2014 IVR-175 (H3N2) NEURAMINIDASE ANTIGEN (PROPIOLACTONE INACTIVATED)",
"substance_type": "structurallyDiverse",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "ORAL",
"spl_meta": {
"480affab-0a9c-4274-ad04-68978973bb25": {
"match": "brand_token",
"title": "H3N2 INFLUENZA NOSODE 4449 (H3N2 INFLUENZA NOSODE) LIQUID [PROFESSIONAL COMPLEMENTARY HEALTH FORMULAS]",
"spl_version": "2",
"published_date": "2026-01-12"
}
},
"productid": "63083-4449_bc143fb1-d232-4a0e-bc1f-6eab849fb0e4",
"productndc": "63083-4449",
"dosage_form": "LIQUID",
"dea_schedule": null,
"product_type": "HUMAN OTC DRUG",
"substance_name": "INFLUENZA A VIRUS A/SOUTH AUSTRALIA/55/2014 IVR-175 (H3N2) NEURAMINIDASE ANTIGEN (PROPIOLACTONE INACTIVATED)",
"proprietary_name": "H3N2 Influenza Nosode",
"active_ingred_unit": "[hp_X]/59mL",
"application_number": null,
"marketing_category": "UNAPPROVED HOMEOPATHIC",
"nonproprietary_name": "H3N2 Influenza Nosode",
"start_marketing_date": "19840815",
"active_numerator_strength": "12"
}Access this data programmatically
Query H3N2 Influenza Nosode and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.